Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
POORTMANS, Philip
BARROS, Alfredo C. de
FREITAS JUNIOR, Ruffo
AUDISIO, Riccardo A.
METERISSIAN, Sarkis
DESNYDER, Sarah M.
BUCHHOLZ, Thomas A.
Citação
EJSO, v.43, n.11, p.2036-2043, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose/Objective(s): Skin sparing mastectomy (SSM) and nipple-sparing mastectomy (NSM) have entered routine surgical practice for breast cancer, though their oncologic safety has not been established in randomized controlled trials. The aim of this study was to evaluate and compare radiation oncologists' and breast surgeons' opinions concerning the indications of post-operative radiation therapy (PORT) after SSM and NSM. Materials/Methods: Radiation oncologists and breast surgeons from North America, South America and Europe were invited to contribute in this study. A 22-question survey was used to evaluate their opinions. Results: A total of 550 physicians (298 radiation oncologists and 252 breast surgeons) answered the survey. The majority of responders affirmed that PORT should be performed in early-stage (stages I and II) breast cancer for patients who present with risk factors for relapse after SSM and NSM. They considered age, lymph node involvement, tumor size, extracapsular extension, involved surgical margins, lymphovascular invasion, triple negative receptor status and multicentric presentation as major risk factors. Considering that after SSM and NSM, residual breast tissue can be left behind, the residual tissue considered as acceptable in the context of an oncologic surgery were 1-5 mm for breast surgeons. There is no consensus for the necessity of evaluating residual breast tissue through breast imaging. Conclusion: Although the indications of PORT after SSM and NSM vary among practitioners, standard risk factors for relapse are considered as important by radiation oncologists and breast surgeons.
Palavras-chave
Breast cancer, Skin-sparing mastectomy, Nipple-sparing mastectomy, Radiation therapy, PMRT
Referências
  1. Ananthakrishnan P, 2012, MINERVA CHIR, V67, P257
  2. Benediktsson KP, 2008, EJSO-EUR J SURG ONC, V34, P143, DOI 10.1016/j.ejso.2007.06.010
  3. Boneti C, 2011, J AM COLL SURGEONS, V212, P93
  4. Boneti C, 2011, J AM COLL SURGEONS, V212, P686, DOI 10.1016/j.jamcollsurg.2010.12.039
  5. Cao D, 2008, ANN SURG ONCOL, V15, P1330, DOI 10.1245/s10434-007-9795-8
  6. Carlson GW, 1996, AM SURGEON, V62, P151
  7. Carlson GW, 2003, ANN SURG ONCOL, V10, P108, DOI 10.1245/ASO.2003.03.053
  8. Cense HA, 2001, EUR J SURG ONCOL, V27, P521, DOI 10.1053/ejso.2001.1130
  9. Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152
  10. Greenway RM, 2005, AM J SURG, V190, P918, DOI 10.1016/j.amjsurg.2005.08.035
  11. Kroll SS, 1999, PLAST RECONSTR SURG, V104, P421, DOI 10.1097/00006534-199908000-00015
  12. Langstein HN, 2003, PLAST RECONSTR SURG, V111, P712, DOI 10.1097/01.PRS.0000041441.42563.95
  13. Langstein HN, 2003, PLAST RECONSTR SURG, V111, P21
  14. Lanitis S, 2010, ANN SURG, V251, P632, DOI 10.1097/SLA.0b013e3181d35bf8
  15. Laronga C, 1999, ANN SURG ONCOL, V6, P609, DOI 10.1007/s10434-999-0609-z
  16. Liang TJ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-194
  17. Lim W, 2010, J SURG ONCOL, V102, P39, DOI 10.1002/jso.21573
  18. Marta GN, 2017, BREAST J, V23, P26, DOI 10.1111/tbj.12683
  19. Marta GN, 2011, REV ASSOC MED BRAS, V57, P468, DOI 10.1590/S0104-42302011000400024
  20. McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8
  21. Medina-Franco H, 2002, ANN SURG, V235, P814, DOI 10.1097/00000658-200206000-00008
  22. Meretoja TJ, 2007, BRIT J SURG, V94, P1220, DOI 10.1002/bjs.5815
  23. Newman LA, 1998, ANN SURG ONCOL, V5, P620, DOI 10.1007/BF02303832
  24. Niemeyer M, 2011, BREAST J, V17, P296, DOI 10.1111/j.1524-4741.2011.01079.x
  25. Petit JY, 2009, BREAST CANCER RES TR, V114, P97, DOI 10.1007/s10549-008-9968-6
  26. Piper M, 2013, ANN PLAS SURG, V70, P435, DOI 10.1097/SAP.0b013e31827e5333
  27. Reefy S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-171
  28. Sacchini V, 2006, J AM COLL SURGEONS, V203, P704, DOI 10.1016/j.jamcollsurg.2006.07.015
  29. Sheikh F, 2011, ANN SURG ONCOL, V18, P952, DOI 10.1245/s10434-010-1406-4
  30. Simmons RM, 1999, ANN SURG ONCOL, V6, P676, DOI 10.1007/s10434-999-0676-1
  31. Slavin SA, 1998, PLAST RECONSTR SURG, V102, P49, DOI 10.1097/00006534-199807000-00008
  32. Sotheran WJ, 2004, ANN ROY COLL SURG, V86, P82, DOI 10.1308/003588404322827437
  33. Torresan RZ, 2005, ANN SURG ONCOL, V12, P1037, DOI 10.1245/ASO.2005.11.027
  34. TOTH BA, 1991, PLAST RECONSTR SURG, V87, P1048, DOI 10.1097/00006534-199106000-00006
  35. Uriburu JL, 2006, BREAST J, V12, P194, DOI 10.1111/j.1075-122X.2006.00240.x
  36. Yi M, 2011, CANCER-AM CANCER SOC, V117, P916, DOI 10.1002/cncr.25505
  37. Yoo H, 2014, EUR RADIOL, V24, P2220, DOI 10.1007/s00330-014-3214-x